No evidence for axonal atrophy in human diabetic polyneuropathy

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 3, 1997, Pages 255-262

  Engelstad, Janean K ^a   Davies, Jenny L ^a   Giannini, Caterina ^a   O'Brien, Peter C ^a   Dyck, Peter J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adaxonal sequestration; Axonal atrophy; Axonal shrinkage; Diabetic polyneuropathy; Index of circularity; Myelin; Nerve fiber

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DIABETIC NEUROPATHY; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; MORPHOMETRICS; NERVE FIBER TRANSECTION; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; SURAL NERVE;

EID: 0030728990     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199703000-00004     Document Type: Article

References (41)

1. Dyck PJ, Kratz KM, Kames JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study. Neurology 1993;43:817-24
2. Pirart J. Diabetes mellitus and its degenerative complications: A prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1978;1:168-88
3. Gregersen G. Diabetic neuropathy: Influence of age, sex metabolic control, and duration of diabetes on motor conduction velocity. Neurology 1967;17:972-80
4. Maser RE, Steenkiste AR, Dorman JS, et al. Epidemiological correlates of diabetic Neuropathy. Report from Pittsburgh epidemiology of diabetes complications study. Diabetes 1989;38:1456-61
5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86
6. Dyck PJ. Resolvable problems in diabetic neuropathy. Journal of NIH Research 1990;2:57-62
7. Dyck PJ, Lais A, Karnes JL, O'Brien P, Rizza R. Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 1986;19:425-39
8. Dyck PJ, Karnes JL, O'Brien PC, Okazaki H, Lais A, Engelstad J. The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol 1986;19:440-49
9. Thomas PK, Lascelles RG. The pathology of diabetic neuropathy. Q J Med 1966;140:489-509
10. Behse F, Buchthal F, Carlsen F. Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 1977;40: 1072-82
11. Powell H. Pathology of diabetic neuropathy: New observations, new hypotheses. Lab Invest 1983;49:515-18
12. Said G, Slama G, Salva J. Progressive centripetal degeneration of axons in small fibre diabetic polyneuropathy. Brain 1983;106:791-807
13. Ohnishi A, Harada M, Tateishi J, Ogata J, Kawanami S. Segmental demyelination and remyelination in lumbar spinal roots of patients dying with diabetes mellitus. Ann Neurol 1983;13:541-48
14. Johnson PC, Doll SC, Cromey DW. Pathogenesis of diabetic neuropathy. Ann Neurol 1986;19:450-57
15. Llewelyn JG, Thomas PK, Gilbey SG, Watkins PJ, Muddle JR. Pattern of myelinated fibre loss in the sural nerve in neuropathy related to type 1 (insulin-dependent) diabetes. Diabetologia 1988;31:162-67
16. Sima AAF, Nathaniel V, Bril V, McEwen TAJ, Greene DA. Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axoglial dysjunction in human diabetic neuropathy. J Clin Invest 1988;81: 349-64
17. Dyck PJ, Giannini C, Lais A. Pathologic alterations of nerves. In: Dyck PJ, Thomas PK, Low PA, Griffin JW, Poduslo JF, eds. Peripheral neuropathy. Philadelphia: W.B. Saunders, 1993;514-95
18. Jakobsen J. Axonal dwindling in early experimental diabetes. I. A study of cross-sectioned nerves. Diabetologia 1976;12:539-46
19. Medori R, Autilio-Gambetti L, Jenich H, Gambetti P. Changes in axon size and slow axonal transport are related in experimental diabetic neuropathy. Neurology 1988;38:597-601
20. Sima AAF, Lorusso AC, Thibert P. Distal symmetric polyneuropathy in the spontaneously diabetic BB-Wistar rat. An ultrastructural and teased fiber study. Acta Neuropathol (Berl) 1982;58:39-47
21. Sharma AK, Thomas PK, Gabriel G, Stolinski C, Docery P, Hollins GW. Peripheral nerve abnormalities in the diabetic mutant mouse. Diabetes 1983;32:1152-61
22. Sima AA, Prashar A, Nathaniel V, Bril V, Werb MR, Greene DA. Overt diabetic neuropathy: Repair of axo-glial dysjunction and axonal atrophy by aldose reductase inhibition and its correlation to improvement in nerve conduction velocity. Diabetic Med 1993;10(2):115-21
23. Sugimura K, Dyck PJ. Sural nerve myelin thickness and axis cylinder caliber in human diabetes. Neurology 1981;31:1087-91
24. Llewelyn JG, Gilbey SG, Thomas PK, King RH, Muddle JR, Watkins PJ. Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy. A clinicopathological study. Brain 1991;114:867-92
25. Dyck PJ, Kratz KM, Lehman KA, et al. The Rochester Diabetic Neuropathy Study: Design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 1991;41:799-807
26. Dyck PJ, Karnes JL, Daube J, O'Brien P, Service FJ. Clinical and neuropathological criteria for the diagnosis and staging of diabetic neuropathy. Brain 1985;108:861-80
27. Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O'Brien PC. Variables influencing neuropathic endpoints: The Rochester Diabetic Neuropathy Study of Healthy Subjects (RDNS-HS). Neurology 1995;45:1115-21
28. Hoffman PN, Griffin JW. The control of axonal caliber. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral Neuropathy. Philadelphia: W. B. Saunders Co., 1993:389-402
29. Ochs S, Brimijoin WS. Axonal transport. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral neuropathy. Philadelphia: W. B. Saunders, 1993:331-60
30. Powell HC, Myers RR. Axonopathy and microangiopathy in chronic alloxan diabetes. Acta Neuropathol (Berl) 1984;65:128-37
31. Korthals JK, Wisniewski HM. Peripheral nerve ischemia. Part 1. Experimental model. J Neurol Sci 1975;24:65-76
32. Dyck PJ, Lambert EH, Windebank AJ, et al. Acute hyperosmolar hyperglycemia causes axonal shrinkage and reduced nerve conduction velocity. Exp Neurol 1981;71:507-14
33. Dyck PJ, Lais A, Karnes J, Sparks M, Dyck PJB. Peripheral axotomy induces neurofilament decrease, atrophy, demyelination and degeneration of root and fasciculus gracilis fibers. Brain Res 1985;340:19-36
34. Dyck PJ, Lais AC, Karnes JL, et al. Permanent axotomy, a model of axonal atrophy and secondary segmental demyelination and remyelination. Ann Neurol 1981;9:575-83
35. Dyck PJ, Low PA, Sparks MF, Hexum LA, Karnes JL. Effect of serum hyperosmolality on morphometry of healthy human sural nerve. J Neuropathol Exp Neurol 1980;39:285-95
36. O'Neill JH, Gilliatt RW. Adaptation of the myelin sheath during axonal atrophy. Acta Neuropathol (Berl) 1987;74(1):62-66
37. O'Neill JH, Jacobs JM, Gilliatt RW, Baba M. Changes in the compact myelin of single internodes during axonal atrophy. Acta Neuropathol (Berl) 1984;63(4):313-18
38. Yoshikawa H, Dyck PJ, Poduslo JF, Giannini C. Polyglucosan body axonal enlargement increases myelin spiral length but not lamellae number. J Neurol Sci 1990;98:107-17
39. Dyck PJ, Johnson WJ, Lambert EH, O'Brien PC. Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin Proc 1971;46:400-31
40. Dyck PJ, Karnes J. Morphometry of neuron columns and fiber tracts in neurobiology and pathology using computer imaging. Trends Neurosci 1981;4:138-41
41. Nukada H, Dyck PJ. Decreased axon caliber and neurofilaments in hereditary motor and sensory neuropathy. Ann Neurol 1984;16: 238-41